|
The Board Certified Medical Affairs Specialist (BCMAS™) Program Recertification Modules
Recertification - Modules
| 
Accredited by IACET/ANSI
As a BCMAS certified professional, you must meet specified requirements in order to maintain and renew your certification every five (5) years. Maintaining your certification is important as a professional. By choosing this option you are required to completed a minimum of 7 modules out of the 14 offered. Upon completing your choice of any 7 modules an Attestation Confirmation modules will be unlocked where you can download your certification.
4.6 | (500 + Graduates)
$599
Complete 7 / 14 Modules
6 Months Access
100% Online & Self Paced
Earn CME/CE Credits
Frequently Bought Together
+
+
Total Price : $1918.98
+
+
Buy all together : $ 1918.98
Learning Objectives
Overview
Out of the 14 courses mentioned in the module breakdown section you are required to complete 7 / 14 to continue your BCMAS certification credential
Patient Outcomes
Learn about how life sciences companies view and utilize patient-reported outcomes in their clinical operations and medical affairs and how inclusion and diversity in clinical trials under represents specific segments of the population
Drug Development
Understand rare disease drug development process, drug abuse and preventions, drug literature evaluation and more
Communication & Real World Evidence
Develop foundational and advanced skills in communication, especially communication related to the life sciences
Medical Congresses
Understand why attending medical congresses is one of the most critical aspects of your profession as an MSL or a medical affairs professional
Medical Strategic Planning
Learn how to utilize social and behavioral aspects of pharmacy to address the following healthcare needs and barriers: medication adherence, communication, disparities in healthcare, public perceptions and roles of healthcare providers, vaccine hesitancy, and medical decision making
Pharmacy Mobile Apps
Learn about the applications support healthcare professionals at the point of care in clinical decision-making for diagnosing medical conditions, assessing risk factors, and dispensing and administering medications and more
Master These Skills
Clinical Trials
Diversity
Medical Congress
Medical Strategic Planning
Communication
Drug Literature
Drug Abuse
Pharma Applications
Health Insurance Policies
Rare Diseases
Drug Development
All ACMA certifications are accredited by IACET/ANSI
25k+
Users
80+
Countries
250+
Companies
Module Breakdown
Module 1
Patient Reported Outcomes
This module aims to provide an in-depth understanding of how life sciences companies view and utilize patient-reported outcomes in their clinical operations and medical affairs teams. Patient- reported outcomes are defined as “any report of the status of a patient’s health condition that comes directly from the patient, without interpretation of the patient’s response by a clinician or anyone else. Because clinical trial data often focuses on clinical outcomes related to improving existing, high-priority mortality and morbidity issues, they often overlook quality-of-life conditions that patients view as equally important to managing their disease. Patient-reported outcomes are increasingly incorporated into patient treatment, as well as clinical testing.
Module 2
Medical Congresses
For MSLs and Medical Affairs professionals, attending medical congresses is one of the most critical aspects of their profession. Medical congresses are the source of scientific information crucial to continuous education on disease awareness, diagnostics, treatments, and patient outcomes. Those who attend medical congresses and professional conferences could monitor their competitors’ development, obtain the newest information, and gauge the status of clinical trials planned to be started soon. Attendance at a medical congress is not only important from a personal and professional development point of view, but it is also an opportunity to interact with key opinion leaders and prescribers. MSLs and Medical Affairs professionals may even meet the up-and-coming rising stars in therapeutic areas of interest. Lastly, Medical Affairs professionals may obtain insights and feedback from essential internal and external stakeholders while attending such conferences.
Module 3
Effective Communication
The changing terrain of communication has made the need for becoming a competent communicator even more significant. This module will help you develop foundational and advanced skills in communication, especially communication related to the life sciences. More specifically, this course will focus on effectively presenting scientific data to a wide variety of audiences and a wide variety of settings. Becoming a competent communicator will help MSLs better know how to navigate the pharmaceutical and life sciences industry best to optimize the cross-functionally of groups across the pharmaceutical landscape.
Module 4
Diversity in Clinical Trials
Clinical trials continue to underrepresent specific segments of the population. Pharmaceutical companies, academic institutions, and clinical research centers need to include diverse participants in clinical trials to collect more robust and complete data that broadens the understanding of gender, racial and ethnic differences in treatment responses. For years, clinical trial sponsors have sought to include a more diverse representation of the patient population in their studies. But clinical trial enrollment continues to underrepresent these racial and ethnic minorities. Despite understanding the causes for why diversity in clinical trial patient recruitment remains low, finding and implementing successful solutions remains a critical challenge. This module aims to provide a better understanding of the current state of diversity in clinical trials, its causes, and potential solutions. It also seeks to present some answers to common barriers preventing more diverse clinical trial participation.
Module 5
Medical Strategic Planning
Whether you have a robust plan with strategic imperatives, priorities, and tactics outlined or are working at a small biotech company where what you do and how you do it is jotted down on a few pieces of paper, the essence is the same. Historically and in most companies today, strategic brand planning is led by a commercial organization and for obvious reasons. Managing a P and L and being accountable for sales and, in turn, revenue for the organization is partly the reason for the historical leadership in addressing the strategy. Today, inputs from cross-functional stakeholders are imperative for the successful development and execution of the company strategy. And having all departments involved in the process ensures buy-in and accountability by all stakeholders.
Download Our Learning Platform App
Go.Learn lets you to access our LMS platform directly from your mobile devices. Through the app, you can easily check programs, complete training material, and view various assets and channels.
